- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02048267
Surgical Outcome and Differences on Histopathology in Patients With Alcoholic & Non Alcoholic Chronic Pancreatitis
A Prospective Study of Surgical Outcome and Differences on Histopathology in Patients With Alcoholic & Non Alcoholic Chronic Pancreatitis
Numerous treatment modalities have been proposed to treat pain in alcoholic and non-alcoholic chronic pancreatitis such as analgesic medication, inhibition of gastric acid production, enzyme substitution, somatostatin analogues, nerve blockade,reduction of oxidative stress and endoscopic pancreatic duct stenting, but none of these concepts have shown long lasting benefits as surgery in clinical studies.Comparison of surgical outcome in non-alcoholic chronic pancreatitis and alcoholic chronic pancreatitis has limited data and differences on the basis of outcome in between alcoholic and non-alcoholic chronic pancreatitis are not available in literature.
Although it is well known that pain is the main symptom of chronic pancreatitis, it has until now been assessed in very common and varying categories. Pain, however, is only one aspect of the large variety of sensitive facets of daily life. In addition to an improvement in pain symptoms and the preservation of pancreatic exocrine and endocrine function and other parameters, occupational rehabilitation of these mostly young patients and quality of life also should be considered in the evaluation of surgical outcome in alcoholic and non-alcoholic chronic pancreatitis.
In this prospective study, we intend to find out if there are any differences in the surgical outcome on the above mentioned parameters in alcoholic and non-alcoholic chronic pancreatitis.We also plan to see if there are differences in the histopathology in these two disease settings.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Chandigarh, India, 160012
- Postgraduate Institute of Medical Education and Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Diagnosis of chronic pancreatitis confirmed by at least 2 of the following:
- Typical Chronic epigastric abdominal pain
- Elevation of serum Amylase>3 times upper limit normal or
- Fecal elastase less than 200ug/g stool.
Confirmatory findings on cross-sectional imaging:
- Changes in size, shape and contour of pancreas
- Dilatation of main pancreatic duct
- Calcification
- Pseudocyst
- Pancreatic duct stricture
- Patients who fulfill the criteria for surgical intervention
Exclusion Criteria:
- Not agreeing for surgical management
- On going acute pancreatitis
- Postop alcohol intake
- Pregnancy.
- Chronic pancreatitis with Malignancy
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Alcoholic
|
Duodenum preserving head resection
|
Non alcoholic
|
Duodenum preserving head resection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Quality of life
Time Frame: Within first 6 months from the time of surgery
|
Within first 6 months from the time of surgery
|
Differences in extent of parenchymal fibrosis, inflammation and ductal obstruction of alcoholic and non alcoholic chronic pancreatitis
Time Frame: Two weeks after surgery
|
Two weeks after surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Pain relief
Time Frame: Within first 6 months after surgery
|
Within first 6 months after surgery
|
HbA1C,Fasting insulin and C-peptide levels
Time Frame: Within first 6 months after surgery
|
Within first 6 months after surgery
|
Fecal elastase levels
Time Frame: Within first 6 months after surgery
|
Within first 6 months after surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Rajesh Gupta, M.Ch., Professor
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NK/338/MS/9609-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatitis, Chronic
-
Changhai HospitalUnknownChronic Pancreatitis | Idiopathic Chronic PancreatitisChina
-
AbbottCompletedExocrine Pancreatic Insufficiency, Chronic PancreatitisJapan
-
Postgraduate Institute of Medical Education and...Completed
-
Dartmouth-Hitchcock Medical CenterCompleted
-
The Cleveland ClinicChiRhoClin, Inc.; The National Pancreas FoundationCompletedChronic PancreatitisUnited States
-
Massachusetts General HospitalTerminatedChronic PancreatitisUnited States
-
Winthrop University HospitalCelgene CorporationTerminatedChronic Pancreatitis
-
Kangen Pharmaceuticals, IncCompletedChronic PancreatitisUnited States, Russian Federation, Ukraine
-
Changhai HospitalEnrolling by invitationChronic PancreatitisChina
Clinical Trials on Frey's procedure/Pylorus preserving pancreatoduodenectomy
-
Hospital Universitari de BellvitgeCompleted
-
GEM Hospital & Research CenterCompletedCholangio Carcinoma | Adenocarcinoma of Head of Pancreas | Duodenal Adenocarcinoma | Carcinoma of Ampulla of VaterIndia
-
Wakayama Medical UniversityCompletedPancreatic Cancer | Bile Duct Cancer | Pancreatitis | Duodenal Cancer | Ampullary CancerJapan
-
Yonsei UniversityUnknown
-
RenJi HospitalUnknown
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedPancreatic CarcinomaUnited States
-
Bradley NeedlemanRecruiting
-
Medtronic - MITGCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteVarian Medical SystemsWithdrawnPancreatic Cancer | Resectable Pancreatic CancerUnited States